Gustavo A. Rosario Benitez

Array ( [id] => 5457860 [patent_doc_number] => 20090258012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/409617 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 90305 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258012.pdf [firstpage_image] =>[orig_patent_app_number] => 12409617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342393 [patent_doc_number] => 20090181043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Method for Producing Human Anti-Thymocyte Immunoglobulins' [patent_app_type] => utility [patent_app_number] => 12/409403 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2527 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181043.pdf [firstpage_image] =>[orig_patent_app_number] => 12409403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975748 [patent_doc_number] => 20110070191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THERE OF' [patent_app_type] => utility [patent_app_number] => 12/933644 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 26270 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070191.pdf [firstpage_image] =>[orig_patent_app_number] => 12933644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315484 [patent_doc_number] => 20090280082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'METHODS FOR TREATING AUTOIMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/395550 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 21845 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280082.pdf [firstpage_image] =>[orig_patent_app_number] => 12395550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9354773 [patent_doc_number] => 08673304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Humanized anti-CD4 antibody with immunosuppressive properties' [patent_app_type] => utility [patent_app_number] => 12/392521 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4434 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12392521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802531 [patent_doc_number] => 08440806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Humanized anti-CD4 antibody with immunosuppressive properties' [patent_app_type] => utility [patent_app_number] => 12/392493 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4436 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12392493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389055 [patent_doc_number] => 08685651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Method for screening for an anti-CD4 antibody suitable for use in immunotherapy' [patent_app_type] => utility [patent_app_number] => 12/392556 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4427 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12392556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484926 [patent_doc_number] => 20090274691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Use of CD25 binding molecules in steroid-resistant patients' [patent_app_type] => utility [patent_app_number] => 12/378454 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6992 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274691.pdf [firstpage_image] =>[orig_patent_app_number] => 12378454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095292 [patent_doc_number] => 20110002927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'ANTIGEN-BINDING POLYPEPTIDES AGAINST CARTILAGE DEGENERATION' [patent_app_type] => utility [patent_app_number] => 12/865365 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10390 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002927.pdf [firstpage_image] =>[orig_patent_app_number] => 12865365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6006981 [patent_doc_number] => 20110059012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'IDENTIFICATION OF CD8+ T CELLS THAT ARE CD161HI AND/OR IL18R (ALPHA) HI AND HAVE RAPID DRUG EFFLUX CAPACITY' [patent_app_type] => utility [patent_app_number] => 12/865221 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13256 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059012.pdf [firstpage_image] =>[orig_patent_app_number] => 12865221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024280 [patent_doc_number] => 20110052606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Humanized Anti-Human NKG2A Monoclonal Antibody' [patent_app_type] => utility [patent_app_number] => 12/811990 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31456 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052606.pdf [firstpage_image] =>[orig_patent_app_number] => 12811990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183741 [patent_doc_number] => 20110123524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHODS FOR TREATING HEMATOPOIETIC MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 12/919708 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12002 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123524.pdf [firstpage_image] =>[orig_patent_app_number] => 12919708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062230 [patent_doc_number] => 20110200617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'COMBINATION THERAPY OF BETA-GLYCOLIPIDS AND ANTIBODIES FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/863162 [patent_app_country] => US [patent_app_date] => 2009-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25813 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200617.pdf [firstpage_image] =>[orig_patent_app_number] => 12863162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8845793 [patent_doc_number] => 08454969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Soluble tumor necrosis factor receptor mutant' [patent_app_type] => utility [patent_app_number] => 12/745724 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6169 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12745724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501682 [patent_doc_number] => 20090162370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR CONDITIONING A SUBJECT FOR HEMATOPOIETIC CELL TRANSPLANTATION' [patent_app_type] => utility [patent_app_number] => 12/338763 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11206 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162370.pdf [firstpage_image] =>[orig_patent_app_number] => 12338763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440965 [patent_doc_number] => 20090092604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity' [patent_app_type] => utility [patent_app_number] => 12/274867 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19611 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092604.pdf [firstpage_image] =>[orig_patent_app_number] => 12274867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545327 [patent_doc_number] => 20090155204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Methods for treating disorders involving monocytes' [patent_app_type] => utility [patent_app_number] => 12/291494 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7333 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155204.pdf [firstpage_image] =>[orig_patent_app_number] => 12291494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455210 [patent_doc_number] => 08716218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Extracellular histones as biomarkers for prognosis and molecular targets for therapy' [patent_app_type] => utility [patent_app_number] => 12/266336 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 21639 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12266336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080107 [patent_doc_number] => 20110142842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/741573 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 28350 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142842.pdf [firstpage_image] =>[orig_patent_app_number] => 12741573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070640 [patent_doc_number] => 20110045490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'BIOMARKER FOR THE PREDICTION OF RESPONSIVENESS TO AN ANTI-TUMOUR NECROSIS FACTOR ALPHA (TNF) TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/740166 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 127 [patent_figures_cnt] => 127 [patent_no_of_words] => 8137 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740166 [rel_patent_id] =>[rel_patent_doc_number] =>)